05-SEP-2026 6:13

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1153 25 1304 90 1096 177 1077
ERLYTX 76 0 0 4 49 9 55
GI 170 4 209 16 195 26 158
GU 380 10 522 53 645 86 524
LEUK 166 2 104 13 158 28 170
LUNG 205 4 209 14 170 35 213
LYMPH 432 6 313 34 414 73 444
MELAN 8 0 0 0 0 3 18
MMYEL 109 0 0 5 61 16 97
MULT 51 1 52 1 12 6 37
OTHER 50 0 0 2 24 5 30
Total 2800 52 2713 232 2824 464 2823

05-SEP-2026 6:13

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 200 2 104 18 219 39 237
ERLYTX 3 0 0 0 0 0 0
GI 1 0 0 1 12 1 6
GU 8 1 52 2 24 3 18
LEUK 617 15 783 55 670 109 664
LUNG 366 3 157 23 280 56 341
OTHER 14 0 0 4 49 5 30
PEOLC 82 0 0 1 12 5 30
PREV 232 0 0 10 122 21 128
SXQOL 658 15 783 52 633 125 761
Total 2181 36 1879 166 2021 364 2215

05-SEP-2026 6:13

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1153 25 1304 90 1096 177 1077
CCD 200 2 104 18 219 39 237
ERLYTX 79 0 0 4 49 9 55
GI 171 4 209 17 207 27 164
GU 388 11 574 55 670 89 542
LEUK 783 17 887 68 828 137 834
LUNG 571 7 365 37 450 91 554
LYMPH 432 6 313 34 414 73 444
MELAN 8 0 0 0 0 3 18
MMYEL 109 0 0 5 61 16 97
MULT 51 1 52 1 12 6 37
OTHER 64 0 0 6 73 10 61
PEOLC 82 0 0 1 12 5 30
PREV 232 0 0 10 122 21 128
SXQOL 658 15 783 52 633 125 761
Total 4981 88 4591 398 4846 828 5039

05-SEP-2026 6:13

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 707 9 470 43 524 95 578
ERLYTX 53 0 0 2 24 7 43
GI 129 3 157 14 170 23 140
GU 284 3 157 33 402 58 353
LEUK 102 1 52 8 97 17 103
LUNG 129 3 157 10 122 25 152
LYMPH 282 4 209 22 268 46 280
MELAN 8 0 0 0 0 3 18
MMYEL 61 0 0 2 24 11 67
MULT 19 0 0 0 0 2 12
OTHER 50 0 0 2 24 5 30
Total 1824 23 1202 136 1655 292 1776

05-SEP-2026 6:13

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 147 1 52 12 146 24 146
ERLYTX 3 0 0 0 0 0 0
GI 1 0 0 1 12 1 6
GU 8 1 52 2 24 3 18
LEUK 252 3 157 16 195 40 244
LUNG 223 1 52 14 170 37 225
OTHER 14 0 0 4 49 5 30
PEOLC 67 0 0 1 12 5 30
PREV 232 0 0 10 122 21 128
SXQOL 485 9 470 42 511 97 590
Total 1432 15 783 102 1241 233 1417

05-SEP-2026 6:13

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 896 13 678 64 779 135 822
CCD 171 1 52 13 158 23 140
ERLYTX 56 0 0 2 24 7 43
GI 139 4 209 17 207 27 164
GU 326 4 209 42 511 74 450
LEUK 357 4 209 25 304 59 359
LUNG 382 5 261 32 390 72 438
LYMPH 282 4 209 22 268 46 280
MELAN 8 0 0 0 0 3 18
MMYEL 61 0 0 2 24 11 67
MULT 44 1 52 5 61 9 55
OTHER 142 0 0 6 73 11 67
PEOLC 68 0 0 0 0 4 24
PREV 232 0 0 10 122 21 128
SXQOL 485 9 470 42 511 97 590
Total 3649 45 2349 282 3432 599 3645

05-SEP-2026 6:13

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 982 24 1252 82 998 164 998
ERLYTX 71 0 0 4 49 9 55
GI 99 2 104 8 97 12 73
GU 270 7 365 38 463 62 377
LEUK 136 2 104 10 122 24 146
LUNG 179 4 209 13 158 31 189
LYMPH 353 5 261 25 304 56 341
MMYEL 96 0 0 5 61 13 79
MULT 51 1 52 1 12 6 37
Total 2237 45 2347 186 2264 377 2295

05-SEP-2026 6:13

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1911 20 1044 144 1753 298 1814
AFFIL 132 1 52 5 61 12 73
CCOP/NCORP 1213 17 887 89 1084 215 1309
Non-SWOG 1722 47 2452 157 1911 300 1826
Total 4978 85 4435 395 4809 825 5022

05-SEP-2026 6:13

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 1 Y 18-AUG-26
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 2 Y 18-AUG-26
LYMPH S2506 NHL, R/R MZL, Mozun +/- Zanu or Pola 1 Y 18-AUG-26

05-SEP-2026 6:13

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 T 27-AUG-26
CCD S1703 Met Breast, STM-monitoring v Usual Care 1 N 15-AUG-26
LUNG A082002 Lung, Adv, Systemic Tx +/- SBRT 1 E 14-AUG-26
GI NRGGI006 Esophagus, Stg I-IVA, PBT vs IMRT 1 E 07-AUG-26
GI NRGGI006 Esophagus, Stg I-IVA, PBT vs IMRT 2 E 07-AUG-26
LUNG S2402 NSCLC, All Stg, Periop Vs Adj Tx 1 E 07-AUG-26

05-SEP-2026 6:13

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 20
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 15
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 13
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 11
LUNG LUNGMAP NSCLC, Adv, Master 2 6
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 4
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 4
GU A032103 Urothelial, All Stg, MRD-Based Adj Tx 0 3
LUNG LUNGMAP NSCLC, Adv, Master 1 3
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 3
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 3